Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Annals of Biomedical Engineering|June 13, 2001
Dielectrical model of cellular structures in radio frequency and microwave spectrum. Electrically interacting versus noninteracting cellsS Y Semenov, G I Simonova, A N Starostin, et al.Cancer|October 1, 1978
Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemiaF Sackmann-Muriel, E Svarch, M Eppinger-Helft, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow TransplantS Pavlovsky, B Koziner, G Milone, et al.Annals of Hematology|October 29, 2021
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patientsCarmen Stanganelli, Davi Coe Torres, Claudia Ortega, et al.Frontiers in Oncology|April 6, 2023
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemiaValeria J Sarapura Martinez, Brenda Buonincontro, Chiara Cassarino, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2021
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotypeEsteban Enrique Elias, Valeria Judith Sarapura Martinez, Mikele Amondarain, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Subdural CMOS optical probe (SCOPe) for bidirectional neural interfacingEric H Pollmann, Heyu Yin, Ilke Uguz, et al.Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and UruguayCarolina Pavlovsky, Isabel Giere, Beatriz Moiraghi, et al.Journal of Medicinal Chemistry|June 29, 2001
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parametersS E Hagen, J Domagala, C Gajda, et al.Clinical Lymphoma, Myeloma & Leukemia|November 16, 2023
Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy AnalysisMaría José Mela Osorio, Beatriz Moiraghi, María Victoria Osycka, et al.Pageof 9